Cimeio Therapeutics raised $50 Million Series A from Versant Ventures
08 April 2022
08 April 2022
Total investments received (USD): 50m
Round value (USD): 50m
Round investors:
Versant Ventures
Company: Cimeio Therapeutics
Related deals
ImmunOs Therapeutics raised $74m in Series B funding backed by Samsara BioCapital, Lightspeed Venture Partners and Gimv
Investments
05 June 2022
CDR-Life raised $76M from Jeito Capital and RA Capital Management
Investments
07 April 2022
Distalmotion raised $90 million in Series E funding led by Revival Healthcare Capital, with participation from 415 Capital
Investments
18 January 2022
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom